What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Immune system
His scientific interests lie mostly in Immunology, Immune system, Immunoglobulin E, Allergy and Immunotherapy.
His Immunology research incorporates themes from Clinical trial and Virology.
His Virology research integrates issues from Antibody and Malaria vaccine.
His biological study spans a wide range of topics, including Surface binding and In vivo.
He combines subjects such as IL-2 receptor, CCR4, Cytokine, Allergen and Anti-Allergic Agents with his study of Immunoglobulin E.
His Immunotherapy study incorporates themes from Immunosuppression, Immune tolerance, Drug and Sensitization.
His most cited work include:
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. (287 citations)
- Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: Results of a phase I trial (142 citations)
- Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen (138 citations)
What are the main themes of his work throughout his whole career to date?
François Spertini mainly focuses on Immunology, Allergy, Allergen, Immune system and Internal medicine.
His Immunology study focuses mostly on Immunoglobulin E, Immunotherapy, Asthma, Vaccination and Antigen.
François Spertini focuses mostly in the field of Allergy, narrowing it down to matters related to Dermatology and, in some cases, Medical history.
His Allergen research is multidisciplinary, relying on both In vivo, Peptide sequence and Peptide.
As a member of one scientific family, François Spertini mostly works in the field of Immune system, focusing on Antibody and, on occasion, Molecular biology and Virology.
His research in Internal medicine is mostly concerned with Adverse effect.
He most often published in these fields:
- Immunology (41.26%)
- Allergy (14.34%)
- Allergen (10.14%)
What were the highlights of his more recent work (between 2014-2021)?
- Immunology (41.26%)
- Internal medicine (9.44%)
- Allergy (14.34%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Immunology, Internal medicine, Allergy, Virology and Clinical trial.
In his study, François Spertini carries out multidisciplinary Immunology and Pandemic research.
His study focuses on the intersection of Internal medicine and fields such as Gastroenterology with connections in the field of Leukocytosis and Glomerulonephritis.
His work carried out in the field of Allergy brings together such families of science as Dermatology and Disease management.
He interconnects Glycoprotein and Antigen in the investigation of issues within Virology.
His Clinical trial research includes themes of Adverse effect, Randomized controlled trial, Plant immunology and Mycobacterium tuberculosis.
Between 2014 and 2021, his most popular works were:
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. (287 citations)
- Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study (100 citations)
- Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial. (94 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Immune system
Immunology, Clinical trial, Internal medicine, Adverse effect and Intensive care medicine are his primary areas of study.
François Spertini has included themes like Tuberculosis vaccines and Tuberculosis in his Immunology study.
The study incorporates disciplines such as Follow up studies, Randomized controlled trial, Plant immunology and Peptide in addition to Clinical trial.
His work deals with themes such as Gastroenterology, Endocrinology and Recombinant DNA, which intersect with Internal medicine.
His research in Adverse effect focuses on subjects like Disease, which are connected to MEDLINE, Immune checkpoint inhibitors, Cancer therapy and T lymphocyte antigen.
His study in Antigen is interdisciplinary in nature, drawing from both Adjuvant, Haplotype and Virology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
